HCV triple therapy in co-infection HIV/HCV is not associated with a different risk of developing major depressive disorder

INTRODUCTION: Hepatitis C (HCV) treatment options have changed with the development of direct activity antivirals (DAAs) and the availability of triple therapies have improved HCV cure rates. A common neuropsychiatric side effect of pegylated-interferon and ribavirin treatment is major depressive di...

Descripción completa

Detalles Bibliográficos
Autores principales: Fialho, Renata, Keller, Majella, File, Alex, Woods, Catherine, Pereira, Marco, Yousseff, Elaney, Tibble, Jeremy, Harrison, Neil, Fisher, Martin, Rusted, Jennifer, Whale, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Poster Sessions – Abstract P097
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224815/
https://www.ncbi.nlm.nih.gov/pubmed/25394133
http://dx.doi.org/10.7448/IAS.17.4.19629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224815/
https://www.ncbi.nlm.nih.gov/pubmed/25394133
http://dx.doi.org/10.7448/IAS.17.4.19629

Ejemplares similares